Although both the American Society of Clinical Oncology and the American Society for Reproductive Medicine state that the impact of cancer treatments on fertility and options for fertility preservation should be addressed with all cancer patients of reproductive age, our results indicate that this important message is reaching approximately half of the intended population in one academic center.

Although few registries have been established or funded, data captured from unplanned pregnancies could become an important component of our public health agenda in the provision of health care for women with glucose intolerance.

We sought to describe the normal distribution of serum estradiol (E₂) rise after gonadotropin-releasing hormone antagonist treatment, determine predictors of pattern of E₂) rise after antagonist treatment and evaluate the prognostic value of the pattern of E₂) rise after antagonist treatment for in vitro fertilization outcomes.

Successful placement of a permanent birth control device at the Detroit Medical Center was achieved in 92.1% of women, with a post-placement pregnancy rate of 0.95%.

Treatment with gonadotropin-releasing hormone analogue determines a down-regulation of several inflammatory proteins in peritoneal fluid of women with endometriosis.

In-office endometrial ablation results in decreased dysmenorrhea and improved mood in relation to decreased menstrual blood loss.

This study suggests that, besides adequate disease-specific treatment, a multidisciplinary approach to care addressing psychosocial aspects would greatly improve the well-being of women with gestational trophoblastic disease.

Human chorionic gonadotropin is seemingly produced alongside luteinizing hormone (LH) in every menstrual cycle in all women, apparently promoted by gonadotropin-releasing hormone, like LH.

Cesarean scar pregnancy must be considered in the differential diagnosis of first-trimester bleeding in women with a history of prior cesarean delivery.

We report a case of intramural pregnancy associated with adenomyosis after in vitro fertilization-embryo transfer, successfully treated with methotrexate injection.

We report a case of gallbladder carcinoma presenting as a pelvic mass with elevated testosterone and CA 125 and clinical history suggestive of Sertoli-Leydig tumor.